Clinical benefit of systemic therapies for recurrent ovarian cancer—ESMO-MCBS scores

K. E. Broekman, M. van Kruchten, H. van Tinteren, C. Sessa, M. Jalving, A. K.L. Reyners

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical benefit of systemic therapies for recurrent ovarian cancer—ESMO-MCBS scores'. Together they form a unique fingerprint.

Medicine & Life Sciences